Pharmaceutical Supply Chain – Patent Considerations
July 28, 2022
By: Aziz Burgy, Ross Blau
American Bar Association
Axinn partner Aziz Burgy and associate Ross Blau co-authored "Pharmaceutical Supply Chain – Patent Considerations," a chapter in the third edition of the American Bar Association publication, Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio.
Click here to learn more about the publication.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
Evidence for Trial Lawyers: Motions, Introducing Evidence, and Objections
Speaking Engagement
Intellectual Property
NYC Bar Trade Secrets Symposium 2024: Navigating the Law of Trade Secrets and Restrictive Covenants
Speaking Engagement
Intellectual Property
Stakeholders 24th Annual CYOC Career Development Conference
Sponsorship
IAM Connect Patent Policy and Litigation Conference 2024
Speaking Engagement
Intellectual Property
CompLaw 33rd Annual Advanced EU Brussels Conference
Speaking Engagement
Jason Murata Named a Profiles in Diversity Journal Diverse Lawyers Making a Difference Award Winner
Awards & Recognitions
Intellectual Property
AIC General Counsel Day 2024
Speaking Engagement
Antitrust
ALM General Counsel Conference East 2024
Speaking Engagement
Antitrust
Global M&A Antitrust Outlook: Trends Shaping Enforcement Strategies
Speaking Engagement
Antitrust